1. Home
  2. NRSN vs LASE Comparison

NRSN vs LASE Comparison

Compare NRSN & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • LASE
  • Stock Information
  • Founded
  • NRSN 2017
  • LASE 2019
  • Country
  • NRSN Israel
  • LASE United States
  • Employees
  • NRSN N/A
  • LASE N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • LASE Industrial Machinery/Components
  • Sector
  • NRSN Health Care
  • LASE Industrials
  • Exchange
  • NRSN Nasdaq
  • LASE Nasdaq
  • Market Cap
  • NRSN 26.0M
  • LASE 29.3M
  • IPO Year
  • NRSN 2021
  • LASE 2022
  • Fundamental
  • Price
  • NRSN $1.18
  • LASE $2.80
  • Analyst Decision
  • NRSN Buy
  • LASE
  • Analyst Count
  • NRSN 2
  • LASE 0
  • Target Price
  • NRSN $14.00
  • LASE N/A
  • AVG Volume (30 Days)
  • NRSN 1.4M
  • LASE 2.2M
  • Earning Date
  • NRSN 09-17-2025
  • LASE 11-13-2025
  • Dividend Yield
  • NRSN N/A
  • LASE N/A
  • EPS Growth
  • NRSN N/A
  • LASE N/A
  • EPS
  • NRSN N/A
  • LASE N/A
  • Revenue
  • NRSN N/A
  • LASE $6,938,027.00
  • Revenue This Year
  • NRSN N/A
  • LASE N/A
  • Revenue Next Year
  • NRSN N/A
  • LASE N/A
  • P/E Ratio
  • NRSN N/A
  • LASE N/A
  • Revenue Growth
  • NRSN N/A
  • LASE 89.34
  • 52 Week Low
  • NRSN $0.80
  • LASE $1.71
  • 52 Week High
  • NRSN $2.60
  • LASE $19.80
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 46.42
  • LASE 48.43
  • Support Level
  • NRSN $1.14
  • LASE $2.36
  • Resistance Level
  • NRSN $1.28
  • LASE $2.79
  • Average True Range (ATR)
  • NRSN 0.15
  • LASE 0.53
  • MACD
  • NRSN 0.03
  • LASE -0.05
  • Stochastic Oscillator
  • NRSN 22.33
  • LASE 30.36

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

Share on Social Networks: